Profound Medical Corp.

$6.92+2.82%(+$0.19)
TickerSpark Score
68/100
Solid
60
Valuation
40
Profitability
55
Growth
84
Health
100
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PROF research report →

52-Week Range61% of range
Low $3.76
Current $6.92
High $8.95

Companywww.profoundmedical.com

Profound Medical Corp. , together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities.

CEO
Arun Swarup Menawat
IPO
2019
Employees
142
HQ
Mississauga, ON, CA

Price Chart

+38.12% · this period
$8.65$6.26$3.87May 20Nov 18May 20

Valuation

Market Cap
$209.40M
P/E
-5.95
P/S
9.89
P/B
4.19
EV/EBITDA
-4.21
Div Yield
0.00%

Profitability

Gross Margin
70.58%
Op Margin
-193.98%
Net Margin
-199.38%
ROE
-75.55%
ROIC
-60.45%

Growth & Income

Revenue
$16.38M · 58.33%
Net Income
$-43,315,210 · -60.76%
EPS
$-1.43 · -33.64%
Op Income
$-41,976,173
FCF YoY
-128.49%

Performance & Tape

52W High
$8.95
52W Low
$3.76
50D MA
$6.41
200D MA
$6.28
Beta
0.50
Avg Volume
191.82K

Get TickerSpark's AI analysis on PROF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
May 16, 25Menawat Arun Swarupbuy12,027
May 15, 25Menawat Arun Swarupbuy10,003
Dec 20, 12HOFER MICHAELsell40,000
Dec 18, 12HOFER MICHAELbuy40,000
Jun 19, 12TEJADA FREDbuy500,000
Jun 19, 12BLANCHET JUSTINbuy500,000
Jun 19, 12Schweitzer John H.buy500,000
Jun 19, 12HOFER MICHAELbuy500,000
Jun 1, 12HOFER MICHAELother0
Jun 19, 12BLANCHET JUSTINother500,000

Our PROF Coverage

We haven't published any research on PROF yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate PROF Report →

Similar Companies